Insurance denials for new hepatitis C drugs remain high nationwide, study suggests
Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the U.S. in 2014. But both public and private insurers continue to deny coverage for these ...
Jun 7, 2018
0
5